Clinical trial

ITAKOS - Italian Observation, Multicenter, Prospective Study of Ofatumumab in RRMS Patients

NCT06345157

StatusACTIVE_NOT_RECRUITING

Study typeOBSERVATIONAL

Start date2024-07-30

PhaseN/A

Study timeline

Study start (actual)2024-07-30Date precision: day

Registry last updated2026-04-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosis, Relapsing-Remittingunresolved

Interventions

OfatumumabDRUG · verified · RxNorm: ofatumumab

Sponsors & collaborators

Novartis Pharmaceuticalslead sponsor

Mapped research locations

NaplesItaly2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06345157 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.